Results
|
1.
|
Guideline-Directed Medical Therapy for the Treatment of Heart Failure with Reduced Ejection Fraction. [Review] MedStar authors:
- Lam, Phillip H
- Patel, Jay
- Rassekh, Negin
- Sheikh, Farooq H
Year: 2023
Citation: - Drugs. 83(9):747-759, 2023 Jun.
Institution:
- MedStar Heart & Vascular Institute
- MedStar Washington Hospital Center
Department: - Cardiovascular Disease Fellowship
Medline publication type:
All authors: - Ahmed A, Deedwania P, Fonarow GC, Lam PH, Patel J, Rassekh N, Sheikh FH
|
|
2.
|
|
|
3.
|
Phase I trial of dasatinib and ixabepilone in patients with solid tumors. MedStar authors:
- Herbolsheimer, Pia M
- Jelinek, James S
- Kapoor, R
- Perry, David J
- Smith, Karen L
- Swain, Sandra M
- Verma, Nitin
- Veytsman, Irina
Citation: - Investigational New Drugs. 31(1):92-8, 2013 Feb.
Institution:
- MedStar Washington Hospital Center
- Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase I
- Journal Article
- Research Support, Non-U.S. Gov't
All authors: - Herbolsheimer P, Jelinek J, Kapoor R, Perry D, Smith KL, Swain SM, Verma N, Veytsman I
|
|
4.
|
COVID-19 Pandemic: Cardiovascular Complications and Future Implications. [Review] MedStar authors:
Year: 2020
Citation: - American Journal of Cardiovascular Drugs. 2020 Jun 23
Institution: - MedStar Union Memorial Hospital
Medline publication type:
All authors: - Akhtar T, Amgai B, Bandyopadhyay D, Chakraborty S, Das A, Fonarow GC, Ghosh RK, Gupta M, Hajra A, Lavie CJ, Naidu SS, Pal I, Patel N
|
|
5.
|
|
|
6.
|
Absence of pharmacokinetic drug-drug interaction of pertuzumab with trastuzumab and docetaxel. MedStar authors:
Year: 2013
Citation: - Anti-Cancer Drugs. 24(10):1084-92, 2013 Nov.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Research Support, Non-U.S. Gov't
All authors: - Baselga J, Brewster M, Cortes J, Garg A, Grincuka E, Hauschild M, Kudaba I, Lum BL, Marier JF, Masuda N, McNally V, Nijem I, Patel T, Ross G, Swain SM, Trinh MM, Visich J
|
|
7.
|
Effect of the BET Protein Inhibitor, RVX-208, on Progression of Coronary Atherosclerosis: Results of the Phase 2b, Randomized, Double-Blind, Multicenter, ASSURE Trial. MedStar authors:
Year: 2016
Citation: - American Journal of Cardiovascular Drugs. 16(1):55-65, 2016 Feb.
Institution: - MedStar Health Research Institute
Medline publication type:
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
All authors: - Ballantyne CM, Barter PJ, Borgman M, Brewer HB, Herrman JP, Hu B, Kastelein JJ, Kataoka Y, Merkely B, Nicholls SJ, Nissen SE, Puri R, Uno K, Wolski K
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
Gout Pharmacotherapy in Cardiovascular Diseases: A Review of Utility and Outcomes. [Review] MedStar authors:
Year: 2021
Citation: - American Journal of Cardiovascular Drugs. 21(5):499-512, 2021 Sep.
Institution: - MedStar Union Memorial Hospital
Medline publication type:
All authors: - Bandyopadhyay D, Deedwania P, Fonarow GC, Ghosh RK, Gupta M, Hajra A, Kaul S, Klein A, Lavie CJ, Mamas M, Roddy E
|
|
12.
|
Pazopanib for the treatment of breast cancer. [Review] MedStar authors:
Year: 2012
Citation: - Expert Opinion on Investigational Drugs. 21(2):217-25, 2012 Feb.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
- Review
All authors: - Amiri-Kordestani L, Swain SM, Tan AR
|
|
13.
|
Novel emerging therapies in atherosclerosis targeting lipid metabolism. [Review] MedStar authors:
Year: 2020
Citation: - Expert Opinion on Investigational Drugs. 29(6):611-622, 2020 Jun.
Institution: - MedStar Union Memorial Hospital
Medline publication type:
All authors: - Aronow WS, Bandyopadhyay D, Blumenthal C, Chatterjee S, Ghosh RK, Gupta M, Jain V, Lavie CJ, Ray KK, Virani SS
|
|
14.
|
|
|
15.
|
Atogepant for migraine. MedStar authors:
Year: 2022
Citation: - Drugs of Today. 58(8):399-405, 2022 Aug.
Department:
- Headache Fellowship
- MedStar Georgetown University Hospital/MedStar Washington Hospital Center
Medline publication type:
|
|
16.
|
|
|
17.
|
|